Clinical studies included a more extensive list of diverse biomarkers associated with atherosclerosis development to include TNF-α, VCAM-1, ICAM-1, and several interleukins, which were not as extensively studied in observational studies. This evidence concerns the gene ICAM1 and atherosclerosis.